NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD

QR Code

NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD

In the article latest published and presented data on 10- and 13-valent pneumococcal conjugate vaccines (PCV10 and PCV13) efficacy and effectiveness in different regions of the world overview is provided for prognosis of expected effect of Russian infants mass immunization as anti-pneumococcal vacci...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. P. Kovtun, V. V. Romanenko
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2014-01-01
Series:	Вопросы современной педиатрии
Subjects:	pneumococcal diseases pneumococcal conjugate vaccines serotypes vaccination effectiveness
Online Access:	https://vsp.spr-journal.ru/jour/article/view/223
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)

The Analysis of Scientific Data on the Efficacy of Pneumococcal Conjugated Vaccine in the Cohort of Children with Bronchial Asthma
by: Tatiana A. Kaliuzhnaia, et al.
Published: (2020-11-01)

A decade of 10-valent pneumococcal conjugate vaccine use in Lithuania: trends in invasive pneumococcal serotype dynamics
by: Aurelija Petrutienė, et al.
Published: (2025-08-01)

Real-World Impact of Pneumococcal Conjugate Vaccines on Vaccine Serotypes and Potential Cross-Reacting Non-Vaccine Serotypes
by: Kevin Apodaca, et al.
Published: (2025-06-01)

Analysis of pneumococcal serotypes distribution to determine a model composition for a Russian pneumococcal conjugate vaccine
by: V. P. Trukhin, et al.
Published: (2022-07-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience
by: N. L. Chernaya, et al.
Published: (2012-02-01)

Bronchopulmonary Pathology Prevalence Among Premature infants and Estimation of Prophylactic Efficacy and Reactogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Premature infants with Bronchopulmonary Dysplasia
by: Vladislav V. Semerikov, et al.
Published: (2020-02-01)

Epidemiology of Streptococcus pneumoniae serotypes in children before and after pneumococcal vaccination
by: I. N. Protasova, et al.
Published: (2021-12-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

Approaches to vaccination of adults against pneumococcal disease in different countries of the world
by: A. S. Korovkin, et al.
Published: (2024-07-01)

Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression
by: I. A. Guchev
Published: (2020-05-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

EXPERIENCE OF APPLICATION AND SAFETY ASSESSMENT OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN UNDER-5 CHILDREN
by: M. V. Fedoseenko, et al.
Published: (2014-09-01)

Pneumococcal serotypes missing prespecified efficacy threshold in immunogenicity trials: real-world evidence from national immunization programs
by: Johnna Perdrizet, et al.
Published: (2024-12-01)

PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2014-01-01)

Serotype distribution among adults with community-acquired pneumococcal pneumonia in Japan between 2019 and 2022: A multicenter observational study
by: Haruka Maeda, et al.
Published: (2025-12-01)

Preventive Efficacy of Pneumococcal Conjugated Vaccine (Population Aspects)
by: I. N. Protasova, et al.
Published: (2022-01-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
by: N. L. Chernaya, et al.
Published: (2013-01-01)

VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS
by: A. V. Rudakova, et al.
Published: (2018-10-01)

13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: Clinical Case
by: Ekaterina I. Alekseeva, et al.
Published: (2019-09-01)

Immunological Efficacy and Safety of a New Pneumococcal Polysaccharide Conjugated Thirteen-Valent Vaccine in the Immunization of Adults and Children (Results of Clinical Studies in the Russian Federation)
by: I. V. Feldblium, et al.
Published: (2022-11-01)

Theoretical Background and Real Results: A Data Review on Vaccine Prevention of Pneumococcal Infection in the World
by: Leyla S. Namazova-Baranova, et al.
Published: (2018-02-01)

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs
by: A. V. Rudakova, et al.
Published: (2019-12-01)

A cost-effectiveness analysis of the 20-valent pneumococcal conjugate vaccine for the prevention of pneumococcal disease among Mexican adults aged ≥60 years
by: Jose Luis Huerta, et al.
Published: (2025-08-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan
by: Shigeki Nakamura, et al.
Published: (2024-12-01)

Clinical Efficacy of Pneumococcal Conjugate 13-valent Vaccine in Young Children
by: S. M. Kharit, et al.
Published: (2016-12-01)

Pneumococcal Infection and Vaccination-Related Knowledge, Attitudes and Practices Among Saudi Residents
by: Wed S. Althobaiti, et al.
Published: (2025-07-01)

Pharmacoeconomic aspects of vaccination against Pneumococcal Infection in Russia
by: A. V. Rudakova, et al.
Published: (2014-09-01)

Vaccination against Pneumococcal Infections of High-Risk People: Pharmacoeconomic Aspects
by: A. V. Rudakova, et al.
Published: (2020-01-01)

Pneumococcal Polysaccharide Conjugated Vaccines and the Problem of Changing Circulating Serotypes of Pneumococcus
by: N. N. Kostyukova, et al.
Published: (2023-11-01)

PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
by: Timothy J Chapman, et al.
Published: (2024-12-01)

Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study
by: L. S. Namazova-Baranova, et al.
Published: (2023-01-01)

Adult indication 13-valent pneumococcal conjugate vaccine clinical development overview: formulation, safety, immunogenicity (dosing and sequence), coadministration, and efficacy
by: Mark A. Fletcher, et al.
Published: (2024-12-01)

Different Technologies for Obtaining Pneumococcal Immunogens
by: I. M. Gruber, et al.
Published: (2021-03-01)

Review of global use of licensed vaccines and development of new vaccines for the prevention of pneumococcal infection
by: M. V. Savkina, et al.
Published: (2021-12-01)

Indirect protection in adults ≥18 years of age from pediatric pneumococcal vaccination: a review
by: Elmira Flem, et al.
Published: (2024-12-01)

EXPERIENCE OF IMPLEMENTATION OF THE COHORT PNEUMOCOCCAL VACCINATION PROGRAM FOR INFANTS IN ST. PETERSBURG
by: S. M. Kharit, et al.
Published: (2014-05-01)

THE EXPERIENCE OF PNEUMOCOCCAL CONJUGATE VACCINE USAGE IN ORPHANAGE INSTITUTION OF THE REPUBLIC OF MORDOVIA
by: A. A. Brovkina, et al.
Published: (2012-11-01)